High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires.
about
Making the next steps in psoriatic arthritis management: current status and future directionsRecent advances in understanding and managing psoriatic arthritisPsoriasis and comorbid diseases: Epidemiology.Diagnosis and management of psoriasis.Diagnostic et prise en charge du psoriasisHypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US womenEffect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter studyUse of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and psoriatic arthritis: a cohort studyPsoriasis, psoriatic arthritis and risk of gout in US men and women.Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasisQualifying unmet needs and improving standards of care in psoriatic arthritis.Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised plaEvidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: systematic review and expert opinion.Personal history of gallstones and risk of incident psoriasis and psoriatic arthritis in U.S. women.Epidemiology of spondyloarthritis.Multidisciplinary dermatology-rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review.The Epidemiology of Psoriatic Arthritis.Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women.Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience.Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA).Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis.Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence.Could Psoriatic Arthritis Be Easily Diagnosed from Current Suspicious Physical Findings in the Dermatology Clinic?Burden of disease: psoriasis and psoriatic arthritis.Diagnosing and treating psoriatic arthritis: an update.Treating moderate to severe psoriasis - best use of biologics.The interleukin-17 pathway in psoriasis and psoriatic arthritis: disease pathogenesis and possibilities of treatment.Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus.Advances in the management of psoriatic arthritis.The indirect costs of psoriatic arthritis: systematic review and meta-analysis.Acute Anterior Uveitis and Spondyloarthritis: More Than Meets the Eye.Secukinumab for treating plaque psoriasis.Emerging biomarkers in psoriatic arthritis.Psoriatic arthritis: complexities, comorbidities and implications for the clinic.Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature.Improvements in diagnostic tools for early detection of psoriatic arthritis.Disease activity in and quality of life of patients with psoriatic arthritis mutilans: the Nordic PAM Study.Benefit of health education by a training nurse in patients with axial and/or peripheral psoriatic arthritis: A systematic literature review.Investigation of 36 non-HLA (human leucocyte antigen) psoriasis susceptibility loci in a psoriatic arthritis cohort.New developments in our understanding of psoriatic arthritis and their impact on the diagnosis and clinical management of the disease.
P2860
Q26783506-EEE2BC6D-8189-467F-8B4A-0148A1148763Q28076527-4BCF679F-10F3-432B-9C16-ABF98FC65F47Q30235889-32B58D8D-D7C3-4E9F-91B0-4048F8B71A89Q33558495-9232E2BE-DE9E-4E2D-A39F-B1272E1A71F0Q33558550-68ED952E-2D01-443A-81F2-5C6B42455CB1Q33848992-15C2BB82-5665-47BA-A30F-1D2643C38DC9Q34228353-3900D80F-CE04-4A96-B3B5-D625F6F98A40Q34283073-050D378B-40E0-4674-8E0D-1E61F8EBBA44Q34474068-75F9DFC1-B68A-45F8-83F8-C34F8AC0B2B7Q34643790-14788C34-93D9-4445-A564-D84D617DB476Q34803582-DB6F2DBF-445D-473D-9A5F-275DF18268C3Q34818891-524B19BC-B67C-4B01-B831-F65ADA751B5AQ35199592-67FFEDAE-D791-49C5-8E11-CABED8A2DB96Q35370653-B1363048-F127-41DF-94B9-843D7FB5D024Q35750729-6622A60C-01D3-4AC5-86B8-2477ABB987F4Q35800115-126F96AA-2B6E-4F3E-ADE9-1D2DEFF225D4Q36175115-A2B5F7E8-417D-4B67-BD66-51526C44CFC0Q36539788-0AD6BBFA-3535-448F-9273-D47E9D4697F6Q37308871-39845114-75DA-4135-B6E1-1CAA4AE98FA4Q37465550-453567CB-E378-4C3C-AF05-87D7E7802722Q37498810-B04AAD45-452B-43EF-8F16-608F1F33DE33Q37613277-97DFD749-663A-4105-B17D-53ED360DC623Q37654037-F0C7618B-546B-4727-8111-7FD18124729FQ38114850-6E7FA213-34BD-4884-87FC-6B2406592E20Q38165235-C4DE3099-9A70-4F4E-AD7C-A62510F6A254Q38174153-85D2EA9B-91AC-4D6F-BA19-33F3A437367EQ38191200-E1174BD0-8748-4B3F-B7EA-6349862F81D6Q38225381-D71C0AA1-A18F-433C-A720-3B15C8B8D4A3Q38227264-C5719EFF-BBE1-4E92-92B3-36475F12747EQ38255820-A5AC2AE4-96B1-4136-843B-43D117773512Q38559007-ABFBBD0B-14FF-4084-B6E1-7263F8E5D127Q38636359-151FFA3A-C5B1-41BD-9D43-CFC1CDF08A6EQ38646234-6EB0EADC-1015-48C4-93E1-FFB87805C2AFQ38688128-0C8B3516-B90C-44B3-A63A-F6F305D7444CQ38809161-901FDBA4-136B-4458-9C57-3965622C9DE2Q38861057-C9725781-9F2A-433A-9399-BDE3E52949B1Q38918484-73A588FB-6D8D-49EE-8521-42DFD5156DE3Q38932791-9D40E7B2-91B3-4787-9225-AF77915C9AD4Q39091750-B10CF281-3149-4199-B63D-C690A51B1554Q39373505-9B32C7A1-2C7D-44C5-B247-589735C4A3CB
P2860
High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
High prevalence of psoriatic a ...... e of screening questionnaires.
@en
High prevalence of psoriatic a ...... e of screening questionnaires.
@nl
type
label
High prevalence of psoriatic a ...... e of screening questionnaires.
@en
High prevalence of psoriatic a ...... e of screening questionnaires.
@nl
prefLabel
High prevalence of psoriatic a ...... e of screening questionnaires.
@en
High prevalence of psoriatic a ...... e of screening questionnaires.
@nl
P2093
P1476
High prevalence of psoriatic a ...... e of screening questionnaires.
@en
P2093
Brian Kirby
Muhammad Haroon
Oliver FitzGerald
P304
P356
10.1136/ANNRHEUMDIS-2012-201706
P407
P577
2012-06-23T00:00:00Z